drugset / Trial / NCT03724357

Blood Donor CVD 9000

NCT03724357

Phase 4 Terminated 3 enrolled University of Maryland, Baltimore
NaSingle-groupOpen-labelBasic science

Summary

This is an open-label, non-randomized study. Volunteers will be vaccinated with the oral cholera vaccine, Vaxchora. Vaxchora has been licensed by the Food and Drug Administration (FDA) for travelers to developing countries. Volunteers will also be asked to provide blood specimens over a follow-up time period of up to eight years. The specimens obtained in this clinical research study will be used to further the investigator's understanding of the protective immunological mechanisms that can be elicited systemically and may be applicable to other enteric pathogens.

Timeline

Start
2018-11-04
Primary completion
2021-10-28
Completion
2021-10-28

Drugs

EvaluationDrugModalityDoseRoute
Subject PXVX0200 Vaccine Oral

Indications

No indication recorded.